KORU Medical Systems, Inc.KRMD recently announced that it has submitted a 510(k) premarket notification for FDA clearance to ...

KORU Medical aims to broaden FreedomEDGE use beyond immunoglobulin indications to reach the oncology infusion centre market.

In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases ...

Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and ...

On December 31, 2025, delivery partners across platforms like Zomato, Swiggy, and Zepto launched a nationwide strike ...

One of the defining public health stories of 2025 was the return of diseases once thought to be under control. As the world ...

USA News Group News Commentary - Recent clinical trials achieving 83% insulin independence rates have ignited a dramatic shift in metabolic disease investment[1], with late-2025 M&A activity reaching ...

Despite renewed efforts to expand primary healthcare, strengthen immunisation, and improve service delivery, the sector continued to face persistent challenges, including disease outbreaks and ...

That’s because of the contradictory nature of Donald Trump’s economic agenda. He is trying to address an “affordability” ...

A quiet policy proposal to shift America’s childhood vaccination schedule toward Denmark’s leaner schedule is on pause.

New Drug Application (NDA) submission on track for January 2026 NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Axsome ...

FDA grants AXS-05 Priority Review designation and sets PDUFA action goal date of April 30, 2026 NEW YORK, Dec. 31, 2025 ...